Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73001 - 73025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	SOCS2	8835	upregulated	Silicon Dioxide analog results in increased expression of SOCS2 mRNA	12q	A24195
Silicon dioxide	Approved	SOD2	6648	upregulated	Silicon Dioxide analog results in increased expression of SOD2 mRNA	6q25.3	A24194 A24195
Silicon dioxide	Approved	SOD2	6648	upregulated	Silicon Dioxide results in increased expression of SOD2 mRNA	6q25.3	A24197 A24207 A24196
Silicon dioxide	Approved	SORBS1	10580	upregulated	Silicon Dioxide results in increased expression of SORBS1 mRNA	10q24.1	A24196
Silicon dioxide	Approved	SORBS2	8470	downregulated	Silicon Dioxide analog results in decreased expression of SORBS2 mRNA	4q35.1	A24195
Silicon dioxide	Approved	SORT1	6272	downregulated	Silicon Dioxide analog results in decreased expression of SORT1 mRNA	1p13.3	A24195
Silicon dioxide	Approved	SOWAHA	134548	downregulated	Silicon Dioxide analog results in decreased expression of SOWAHA mRNA	5q31.1	A24195
Silicon dioxide	Approved	SOWAHD	347454	downregulated	Silicon Dioxide analog results in decreased expression of SOWAHD mRNA	Xq24	A24195
Silicon dioxide	Approved	SOX12	6666	downregulated	Silicon Dioxide results in decreased expression of SOX12 mRNA	20p13	A24196
Silicon dioxide	Approved	SOX17	64321	downregulated	Silicon Dioxide analog results in decreased expression of SOX17 mRNA	8q11.23	A24195
Silicon dioxide	Approved	SOX2	6657	downregulated	Silicon Dioxide analog results in decreased expression of SOX2 mRNA	3q26.33	A24195
Silicon dioxide	Approved	SOX21	11166	downregulated	Silicon Dioxide analog results in decreased expression of SOX21 mRNA	13q32.1	A24195
Silicon dioxide	Approved	SOX3	6658	upregulated	Silicon Dioxide analog results in increased expression of SOX3 mRNA	Xq27.1	A24195
Silicon dioxide	Approved	SOX4	6659	upregulated	Silicon Dioxide results in increased expression of SOX4 mRNA	6p22.3	A24196
Silicon dioxide	Approved	SOX8	30812	upregulated	Silicon Dioxide analog results in increased expression of SOX8 mRNA	16p13.3	A24195
Silicon dioxide	Approved	SOX9	6662	upregulated	Silicon Dioxide results in increased expression of SOX9 mRNA	17q24.3	A24197 A24196
Silicon dioxide	Approved	SOX9-AS1	400618	downregulated	Silicon Dioxide analog results in decreased expression of SOX9-AS1 mRNA	17q24.3	A24195
Silicon dioxide	Approved	SP1	6667	downregulated	Silicon Dioxide results in decreased expression of SP1 mRNA	12q13.13	A24196
Silicon dioxide	Approved	SP100	6672	downregulated	Silicon Dioxide results in decreased expression of SP100 mRNA	2q37.1	A24196
Silicon dioxide	Approved	SP140L	93349	upregulated	Silicon Dioxide analog results in increased expression of SP140L mRNA	2q37.1	A24195
Silicon dioxide	Approved	SP2	6668	upregulated	Silicon Dioxide results in increased expression of SP2 mRNA	17q21.32	A24196
Silicon dioxide	Approved	SP4	6671	upregulated	Silicon Dioxide analog results in increased expression of SP4 mRNA	7p15.3	A24194
Silicon dioxide	Approved	SP5	389058	downregulated	Silicon Dioxide analog results in decreased expression of SP5 mRNA	2q31.1	A24195
Silicon dioxide	Approved	SPACA6	147650	downregulated	Silicon Dioxide analog results in decreased expression of SPACA6 mRNA	19q13.41	A24195
Silicon dioxide	Approved	SPACA9	11092	downregulated	Silicon Dioxide analog results in decreased expression of SPACA9 mRNA	9q34.13	A24195

Displaying entries 73001 - 73025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability